UHPLC-MS/MS Analysis of Cannabidiol and Its Metabolites in Serum of Patients with Resistant Epilepsy Treated with CBD Formulations
Cannabidiol (CBD) is a promising therapeutic agent with analgesic, myorelaxant, and anti-epileptic actions. Recently, a purified form of CBD (Epidiolex<sup>®</sup>) has been approved by the European Medicines Agency (EMA) for the treatment of two highly-refractory childhood-onset epileps...
Tallennettuna:
Päätekijät: | , , , , , , , , , , , , |
---|---|
Aineistotyyppi: | Kirja |
Julkaistu: |
MDPI AG,
2021-06-01T00:00:00Z.
|
Aiheet: | |
Linkit: | Connect to this object online. |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Internet
Connect to this object online.3rd Floor Main Library
Hyllypaikka: |
A1234.567 |
---|---|
Nide 1 | Saatavissa |